Targeting viral Bcl-2 proteins for therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/637336

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Failure to correctly regulate cell death leads to a number of diseases, including cancers and auto-immune diseases. Viruses have the ability to hijack the host cell death machinery for their own benefit. Viral infections have been linked to a number of cancers. We aim to target the ability of viruses to hijack the process of cell death to develop new treatments against virus-linked cancers including Burkitt's Lymphoma and Nasopharyngeal Carcinoma.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2012

Funding Scheme: Project Grants

Funding Amount: $311,866.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Burkitts Lymphoma | Cancer | Epstein-Barr Virus | Hodgkin's Lympomal | Nasopharyngeal Carcinoma | Small molecule drugs

Related Links